Sen04 0000 01
Sensorcaine Injection, Solution
Product Images NDC 63323-462
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Sensorcaine (NDC 63323-462). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Sen04 0000 02
Chemical structure of bupivacaine hydrochloride, showing the molecular formula with a piperidine ring and aromatic ring, alongside hydrochloride and water components.*
Sen04 0000 03
Chemical structure diagram depicting the molecular arrangement of the active ingredient in SENSORCAINE MPF, which includes bupivacaine hydrochloride, showing the benzene ring with hydroxyl groups and attached functional groups.*
Sen04 0000 04
Label for Sensorcaine MPF injection, a solution containing Bupivacaine HCl and Epinephrine bitartrate. The strength is 0.5% (5 mg/mL) with epinephrine 1:200,000, provided as 150 mg per 30 mL in a single dose vial. The label specifies use for nerve block, caudal, and epidural anesthesia, is methylparaben free, and includes a warning that it contains sulfites. It is Rx only and labeled by Fresenius Kabi USA, LLC.*
Sen04 0000 05
Label for SENSORCAINE MPF Injection, a solution containing Bupivacaine HCl 0.5% (5 mg/mL) and Epinephrine bitartrate 0.005 mg/mL. This product is indicated for nerve block, caudal, and epidural anesthesia, not for spinal anesthesia, packaged as 25 single-dose vials of 30 mL each. The label includes warnings about sulfites, storage instructions, and manufacturer details for Fresenius Kabi USA.*
Sen04 0000 06
Label for Sensorcaine MPF (Bupivacaine HCl Injection, USP) showing strength 0.25% (2.5 mg/mL), with a total of 75 mg per 30 mL in a single dose vial. The label states use for infiltration, nerve block, caudal and epidural anesthesia, and notes it is not for spinal anesthesia. The vial is methylparaben free and labeled for prescription use only.*
Sen04 0000 07
Packaging label for Sensorcaine-MPF (Bupivacaine HCl Injection, USP) 0.25% solution, providing 75 mg per 30 mL (2.5 mg/mL). The label indicates it is for infiltration, nerve block, caudal, and epidural anesthesia, noting it is not for spinal anesthesia. It is methylparaben free and labeled as single dose vials, 30 mL each, with 25 vials per package. The product is by Fresenius Kabi USA, LLC, with storage instructions and cautions about solution appearance and sterilization by autoclaving.*
Sen04 0000 08
Label for Sensorcaine (Bupivacaine HCl) Injection, USP 0.25% strength, containing 125 mg per 50 mL (2.5 mg/mL). This is a 50 mL multiple dose vial indicated for infiltration and nerve block only. The label specifies it is not for caudal, epidural, or spinal anesthesia and is for prescription use only.*
Sen04 0000 09
Label for SENSORCAINE MPF (Bupivacaine HCl Injection, USP) 0.25% (2.5 mg per mL), 125 mg per 50 mL solution for injection. The product is indicated for infiltration and nerve block only and is not for caudal, epidural, or spinal anesthesia. Each mL contains Bupivacaine HCl 2.5 mg, sodium chloride 8 mg, and methylparaben 1 mg. Manufactured by Fresenius Kabi USA, LLC, the label includes storage instructions and cautions against use if discolored or containing precipitate.*
Sen04 0000 10
Label of Sensorcaine-MPF (Bupivacaine HCl Injection, USP) showing 0.5% strength with 150 mg per 30 mL (5 mg/mL) concentration. The label specifies use for nerve block, caudal and epidural anesthesia, and states it is methylparaben free. The package is a 30 mL single dose vial, labeled Rx only.*
Sen04 0000 11
The label for Sensorcaine-MPF injection, solution, containing Bupivacaine HCl at 0.5% strength (5 mg/mL). The package includes 25 single-dose vials of 30 mL each. It is intended for nerve block, caudal, and epidural anesthesia, not for spinal anesthesia. Methylparaben free, manufactured by Fresenius Kabi USA, LLC.*
Sen04 0000 12
The labeling for Sensorcaine Injection, USP (Bupivacaine HCl) shows a concentration of 0.5% (5 mg/mL), with a total of 250 mg per 50 mL vial. It is indicated for nerve block only and specifies it is not for caudal, epidural, or spinal anesthesia. The vial is a 50 mL multiple dose container labeled Rx only.*
Sen04 0000 13
SENSORCAINE MPF 0.5% (Bupivacaine HCl Injection, USP) solution, 5 mg/mL strength in a 50 mL multiple dose vial. Label indicates 250 mg per 50 mL, for nerve block only, not for caudal, epidural, or spinal anesthesia. Manufactured by Fresenius Kabi USA, LLC, with storage instructions and ingredient details.*
Sen04 0000 14
Label for SENSORCAINE MPF injection, containing Bupivacaine HCl and Epinephrine. The concentration shown is 0.75% (7.5 mg/mL of bupivacaine) with epinephrine at 1:200,000 (as bitartrate). The vial volume is 30 mL single dose. Indicated for epidural and retrobulbar anesthesia, not for obstetric or spinal anesthesia. Methylparaben free and contains sulfites. Rx only.*
Sen04 0000 15
Sensorcaine MPF 0.75% (Bupivacaine HCl and Epinephrine Injection, USP) solution for injection, 7.5 mg/mL Bupivacaine and 0.005 mg/mL Epinephrine (as bitartrate), packaged as 25 single dose vials of 30 mL each. Label indicates use for epidural and retrobulbar anesthesia, not for obstetric or spinal anesthesia. Manufactured by Fresenius Kabi USA, LLC.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
